Medicare Change Heralds Easier Device Trial Reimbursements

Law360, New York (July 26, 2013, 8:01 PM EDT) -- Medicare’s decisions about whether to cover certain costs in clinical trials for medical devices could become much more consistent under a proposal to centralize review instead of using numerous contractors, though concerns linger about how reviewers will apply potentially subjective standards, experts say.

In a proposed rule issued earlier this month, the Centers for Medicare and Medicaid Services floated the centralization plan and outlined more than a dozen standards to which trials must adhere if taxpayers are going to foot part of the bill.

“Appropriate study...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.